Natus Medical (Natus Medical) Cash-to-Debt : 8.23 (As of Mar. 2022)

View and export this data going back to 2001. Start your Free Trial

What is Natus Medical Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Natus Medical's cash to debt ratio for the quarter that ended in Mar. 2022 was 8.23.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Natus Medical could pay off its debt using the cash in hand for the quarter that ended in Mar. 2022.

The historical rank and industry rank for Natus Medical's Cash-to-Debt or its related term are showing as below:

NTUS's Cash-to-Debt is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.875
* Ranked among companies with meaningful Cash-to-Debt only.

Natus Medical Cash-to-Debt Historical Data

The historical data trend for Natus Medical's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Natus Medical Cash-to-Debt Chart

Natus Medical Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Cash-to-Debt

Get a 7-Day Free Trial

0.58

0.54

0.87

1.14

6.43

Natus Medical Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Cash-to-Debt	Get a 7-Day Free Trial															1.59	4.49	5.49	6.43	8.23

Competitive Comparison of Natus Medical's Cash-to-Debt

For the Medical Devices subindustry, Natus Medical's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natus Medical's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Natus Medical's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Natus Medical's Cash-to-Debt falls into.

Natus Medical Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Natus Medical's Cash to Debt Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	75.595	/	(4.964	+	6.797)
	=	6.43

Natus Medical's Cash to Debt Ratio for the quarter that ended in Mar. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	84.285	/	(4.482	+	5.755)
	=	8.23

Natus Medical (NAS:NTUS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Natus Medical Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Natus Medical's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Natus Medical (Natus Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Natus Medical Inc (NAS:NTUS) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

3150 Pleasant View Road, Middleton, WI, USA, 53562

Website

https://www.natus.com

Natus Medical Inc is a provider of newborn care, neurology, and hearing and balance assessment healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. It is divided into three business units: Neuro, Newborn Care, and Hearing and Balance. The company generates a majority of its revenue from the Neurology business unit which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care, and neurosurgery.

Executives

Chung Dong Chune Christopher	officer: Vice President Medical Affairs	1501 INDUSTRIAL ROAD SAN CARLOS CA 94070
Bryant M Moore	director	181 HARVEST LANE PITTSBORO NC 27312
Eric Guerin	director	1950 HASSELL ROAD, HOFFMAN ESTATES IL 60169
Ilan Daskal	director	1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Alice D. Schroeder	director	1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Lisa Wipperman Heine	director	1244 76TH STREET WEST, INVER GROVE HEIGHTS MN 55077
Jonathan Kennedy	director, officer: Sr. VP, CFO	INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Ken Ludlum	director
Robert A Gunst	director
Noll Austin Francis Iii	officer: VP/GM Neurology	9805 FALLEN LEAF DRIVE MIDDLETON WI 53562
Thomas Joseph Sullivan	director	64 PETTIT PL PRINCETON NJ 08540
Benjamin Drew Davies	officer: Sr. VP, CFO	1501 INDUSTRIAL ROAD, SAN CARLOS X1 94070
Joshua Levine	director	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Sharon Villaverde	officer: Interim CFO	11780 U.S. HIGHWAY 1, SUITE 600, PALM BEACH GARDENS FL 33408
William M Moore	director